Splanchnic vein thrombosis (SVT) has been associated with a hypercoagulable state. Thrombin-activatable fibrinolysis inhibitor (TAFI) may contribute to a hypercoagulable state, and therefore we were interested in the role of TAFI in SVT...
Keywords: Thrombin-activatable fibrinolysis inhibitor, Budd-Chiari syndrome, portal vein thrombosis, single nucleotide polymorphism, splanchnic vein thrombosis, inflammation, fibrinolysis
00/0000 | Thrombosis and Haemostasis, Schattauer